These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38693422)

  • 1. New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model.
    Yu D; Yang J; Wang B; Li Z; Wang K; Li J; Zhu C
    Cancer Immunol Immunother; 2024 May; 73(6):112. PubMed ID: 38693422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the CD8 + T-cell Related Signature for Predicting the Prognosis of Gastric Cancer Based on Integrated Analysis of Bulk and Single-cell RNA Sequencing Data.
    Zhu ZG; Wang Z; Wu Q; Miao DL; Jin YQ; Chen L
    J Immunother; 2024 Sep; 47(7):239-248. PubMed ID: 38809517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing machine learning to integrate single-cell and bulk RNA sequencing data for constructing and validating a novel cell adhesion molecules related prognostic model in gastric cancer.
    Chen C; Chen X; Hu Y; Pan B; Huang Q; Dong Q; Xue X; Shen X; Chen X
    Comput Biol Med; 2024 Sep; 180():108998. PubMed ID: 39137671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell analysis uncovers high-proliferative tumour cell subtypes and their interactions in the microenvironment of gastric cancer.
    Zhang W; Wang X; Dong J; Wang K; Jiang W; Fan C; Liu H; Fan L; Zhao L; Li G
    J Cell Mol Med; 2024 Jun; 28(12):e18373. PubMed ID: 38894657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An individualized stemness-related signature to predict prognosis and immunotherapy responses for gastric cancer using single-cell and bulk tissue transcriptomes.
    Zheng L; Chen J; Ye W; Fan Q; Chen H; Yan H
    Cancer Med; 2024 Jan; 13(1):e6908. PubMed ID: 38168907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of signature based on T cell-related genes in stomach adenocarcinoma by analysis of single cell sequencing data.
    Wang H; An N; Pei A; Sun Y; Li S; Chen S; Zhang N
    Aging (Albany NY); 2024 Mar; 16(7):6035-6053. PubMed ID: 38536020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
    Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
    Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancer.
    Wang J; Feng J; Chen X; Weng Y; Wang T; Wei J; Zhan Y; Peng M
    Aging (Albany NY); 2024 Apr; 16(8):7331-7356. PubMed ID: 38656888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
    Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
    Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the immune escape mechanisms in gastric cancer patients based on the deep AI algorithms and single-cell sequencing analysis.
    Chen W; Liu X; Wang H; Dai J; Li C; Hao Y; Jiang D
    J Cell Mol Med; 2024 May; 28(10):e18379. PubMed ID: 38752750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
    Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
    Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing immunotherapy for melanoma: the critical role of single-cell analysis in identifying predictive biomarkers.
    He R; Lu J; Feng J; Lu Z; Shen K; Xu K; Luo H; Yang G; Chi H; Huang S
    Front Immunol; 2024; 15():1435187. PubMed ID: 39026661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
    Hu B; Meng Y; Qu C; Wang BY; Xiu DR
    Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma.
    Liu R; Liu Y; Zhang F; Wei J; Wu L
    Front Immunol; 2023; 14():1146411. PubMed ID: 37063920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
    Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
    Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy.
    Zhao Y; Liu Z; Deng K; Qu H; Zhang Q; Zhou P; Yang M; Yang X; Wang H; Li R; Xia J
    Int Immunopharmacol; 2024 May; 132():111998. PubMed ID: 38593510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying and validating angiogenesis-related genes remodeling tumor microenvironment and suppressing immunotherapy response in gastric cancer.
    Li G; Li Z; Shen J; Ma X; Zheng S; Zheng Y; Cao K; Dong N
    Gene; 2024 Nov; 928():148796. PubMed ID: 39067544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and validation of a novel senescence-related risk score can help predict the prognosis and tumor microenvironment of gastric cancer patients and determine that STK40 can affect the ROS accumulation and proliferation ability of gastric cancer cells.
    Sun W; Yuan Y; Chen J; Bao Q; Shang M; Sun P; Peng H
    Front Immunol; 2023; 14():1259231. PubMed ID: 37915566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. System analysis based on T-cell exhaustion-related genes identifies PTPRT as a promising diagnostic and prognostic biomarker for gastric cancer.
    Wu J; Li L; Cheng Z
    Sci Rep; 2024 Sep; 14(1):21049. PubMed ID: 39251810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis reveals that P4HA3 is a prognostic and diagnostic gastric cancer biomarker that can predict immunotherapy efficacy.
    Yu Y; Luo K; Liu M; Chen L; Gao X; Zhang L; Li X; Zhang H
    Sci Rep; 2024 Oct; 14(1):22959. PubMed ID: 39362976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.